Navigation Links
Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
Date:7/1/2008

BANNOCKBURN, Ill., July 1 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company today announced it has entered into a lease agreement to establish its headquarters in Bannockburn, Illinois.

"This is another key milestone reached by Pinnacle to bring the top management together, consolidate resources in one office, and give additional momentum to the future expansion of the company," said Guillermo Herrera, chairman of the board of Pinnacle Biologics.

James R. Miller, President & CEO stated, "This is a pivotal strategic decision made by the Pinnacle Founders. Now that we have the headquarters staff consolidated in Bannockburn, Ill., we will be able to optimize our resources in Maryland and The Netherlands."

The company today further announced it has appointed Sandra (Sandy) Miller, a Principal of Hewitt Associates, to the Board of Directors. Sandy has over 20 years of experience in human resources consulting.

"The founders of Pinnacle welcome Sandy to the Board of Directors," said Mr. Herrera, chairman of the board of Pinnacle Biologics. "Sandy brings a breadth of experience to Pinnacle including her human resources and compensation knowledge, global talent management expertise, and overall business acumen."

Sandy commented, "Pinnacle's innovative approach to worldwide commercialization of biotechnology/pharmaceutical products is a demonstration of the strength and experience of the seasoned veterans leading this organization. I am pleased to work with all of them."

About Pinnacle Biologics

Founded in 2007 by former Abbott Laboratories executives Guillermo Herrera, James Miller, and Viren Grover, Pinnacle Biologics is a premier international company that excels in assisting pharmaceutical and biotech companies that require a total solution in either launching products or maximizing/monetizing the value of products late in their life cycle. Pinnacle forms exclusive relationships with research-based pharmaceutical multi-national corporations and biotechnology companies to take products to the next level.

Pinnacle provides a full range of services including regulatory, sales, marketing, distribution (including billing and collections), pharmacovigilence, product safety, market research and administrative services.
Website: http://www.pinnaclebiologics.com

COMPANY CONTACT:

James R. Miller, Pinnacle

President & CEO

1 (240) 372-4599


'/>"/>
SOURCE Pinnacle Biologics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pinnacle Biologics Announces Logistics Services Agreement With the Movianto Group
2. Pinnacle Biologics Announces Contract With Chiltern
3. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
4. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
5. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
6. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
7. Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
8. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
9. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
10. MedImmune Submits Biologics License Application to FDA for Motavizumab
11. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... ... ... Shimadzu Scientific Instruments will showcase several new products, including ... and present on the analysis of mycotoxins and medical cannabis at the Pittcon ... the Georgia World Congress Center in Atlanta, Georgia. , Attendees should stop ...
(Date:2/4/2016)... , Feb. 4, 2016 Beike Biotechnology, the ... medical institutions attended a ceremony in late 2015 to ... cell therapy in 2016. --> ... Translation Platform for Personalized Cell Therapy" was hosted by ... Production Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. ... ("DelMar" and the "Company"), a biopharmaceutical company focused on the ... it will present at the 18 th Annual ... 2016 at 10:00 a.m. EST in New York, ... president and CEO, will provide an update on the ongoing ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate Growth ... analysis of the digital and computed radiography markets in ... , and Indonesia (TIM). It ... market size, as well as regional market drivers and ... discusses market penetration and market attractiveness, both for digital ...
Breaking Biology News(10 mins):